Brief: Biosynex H1 Consolidated Revenue Up At 44.3 Million Euros
July 21 (Reuters) - BIOSYNEX SA ALBIO.PA :
* H1 CONSOLIDATED REVENUE EUR 44.3 MILLION VERSUS EUR 18.0
MILLION
YEAR AGO
* ANTICIPATES CONTINUED HIGH GROWTH IN THE SECOND HALF OF
THE YEAR
Source text: https://bit.ly/2OJV3ey
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals